References
- •= papers of interest
- ••= papers of particular interest
- Salvarani C, Brown RD Jr., Calamia KT, Miller DV, et al. Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol. 2007;62(5):442–451.
- Salvarani C, Brown RD Jr., Hunder GG. Adult primary central nervous system vasculitis. Lancet. 2012;380(9843):767–777.
- Salvarani C, Brown RD Jr., Christianson T, et al. An update of the mayo clinic cohort of patients with adult primary central nervous system vasculitis: description of 163 patients. Medicine (Baltimore). 2015;94(21):e738.
- Salvarani C, Brown RD Jr., Christianson TJ, Miller DV, et al. Adult Primary Central Nervous System Vasculitis Treatment and Course: Analysis of One Hundred Sixty-Three Patients. Arthritis Rheumatol. 2015;67(6):1637–1645.
••The largest cohort of adult patients with PACNS to date.
- de Boysson H, Zuber M, Naggara O, Bousser MG, et al. Primary angiitis of the central nervous system: description of the first fifty-two adults enrolled in the French cohort of patients with primary vasculitis of the central nervous system. Arthritis Rheumatol. 2014;66(5):1315–1326.
••Another large and independent cohort of adult patients with PACNS.
- Neel A, Pagnoux C. Primary angiitis of the central nervous system. Clin Exp Rheumatol. 2009;27(1 Suppl 52):S95–107.
- Cellucci T, Tyrrell PN, Twilt M, et al. Distinct phenotype clusters in childhood inflammatory brain diseases: implications for diagnostic evaluation. Arthritis Rheumatol. 2014;66(3):750–756.
- Benseler S, Schneider R. Central nervous system vasculitis in children. Curr Opin Rheumatol. 2004;16(1):43–50.
- Benseler SM, Silverman E, Aviv RI, Tyrrell PN, et al. Primary Central Nervous System Vasculitis in Children. Arthritis Rheum. 2006;54(4):1291–1297.
••The largest cohort of children with PACNS to date.
- MacLaren K, Gillespie J, Shrestha S, et al. Primary angiitis of the central nervous system: emerging variants. QJM. 2005;98(9):643–654.
- Oon S, Roberts C, Gorelik A, et al. Primary angiitis of the central nervous system: experience of a victorian tertiary-referral hospital. Intern Med J. 2013;43(6):685–692.
- Alrawi A, Trobe JD, Blaivas M, et al. Brain biopsy in primary angiitis of the central nervous system. Neurology. 1999;53(4):858–860.
- Hutchinson C, Elbers J, Halliday W, et al. Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study. Lancet Neurol. 2010;9(11):1078–1084.
- Malik MA, Zia-ur-Rehman M, Nadeem MM, et al. Childhood primary angiitis of the central nervous system. J Coll Physicians Surg Pak. 2012;22(9):570–574.
- Hajj-Ali RA, Singhal AB, Benseler S, et al. Primary angiitis of the CNS. Lancet Neurol. 2011;10(6):561–572.
- Calabrese LH. Vasculitis of the central nervous system. Rheum Dis Clin North Am. 1995;21(4):1059–1076.
- Calabrese LH, Mallek JA. Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore). 1988;67(1):20–39.
••The princeps article on PACNS and its diagnostic criteria.
- Miller DV, Salvarani C, Hunder GG, et al. Biopsy findings in primary angiitis of the central nervous system. Am J Surg Pathol. 2009;33(1):35–43.
- Giannini C, Salvarani C, Hunder G, et al. Primary central nervous system vasculitis: pathology and mechanisms. Acta Neuropathol. 2012;123(6):759–772.
- Twilt M, Benseler SM. The spectrum of CNS vasculitis in children and adults. Nat Rev Rheumatol. 2011;8(2):97–107.
•A comprehensive review, emphasizing the differences between adult and children PACNS.
- Hajj-Ali RA. Primary angiitis of the central nervous system: differential diagnosis and treatment. Best Pract Res Clin Rheumatol. 2010;24(3):413–426.
- Vera-Lastra O, Sepulveda-Delgado J, Cruz-Dominguez MD, et al. Primary and secondary central nervous system vasculitis: clinical manifestations, laboratory findings, neuroimaging, and treatment analysis. Clin Rheumatol. 2015;34:729–738.
- Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11.
- Hajj-Ali RA, Calabrese LH. Central nervous system vasculitis. Curr Opin Rheumatol. 2009;21(1):10–18.
- Benseler SM, Deveber G, Hawkins C, et al. Angiography-negative primary central nervous system vasculitis in children: a newly recognized inflammatory central nervous system disease. Arthritis Rheum. 2005;52(7):2159–2167.
- Salvarani C, Brown RD Jr., Calamia KT, et al. Primary central nervous system vasculitis with prominent leptomeningeal enhancement: a subset with a benign outcome. Arthritis Rheum. 2008;58(2):595–603.
- Salvarani C, Brown RD Jr., Calamia KT, et al. Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy. Rheumatology (Oxford). 2008;47(11):1671–1677.
- Guillevin L, Pagnoux C, Seror R, et al. The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French vasculitis study group (FVSG) cohort. Medicine (Baltimore). 2011;90(1):19–27.
- Pagnoux C, Mahr A, Hamidou MA, et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med. 2008;359(26):2790–2803.
- Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349(1):36–44.
- Monach PA, Arnold LM, Merkel PA. Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review. Arthritis Rheum. 2010;62(1):9–21.
- Yilmaz N, Emmungil H, Gucenmez S, et al. Incidence of cyclophosphamide-induced urotoxicity and protective effect of mesna in rheumatic diseases. J Rheumatol. 2015;42(9):1661–1666.
- De Boysson H, Arquizan C, Guillevin L, et al. Rituximab for primary angiitis of the central nervous system: report of 2 patients from the French COVAC cohort and review of the literature. J Rheumatol. 2013;40(12):2102–2103.
- Salvarani C, Brown RD Jr., Calamia KT, et al. Efficacy of tumor necrosis factor alpha blockade in primary central nervous system vasculitis resistant to immunosuppressive treatment. Arthritis Rheum. 2008;59(2):291–296.
- Batthish M, Banwell B, Laughlin S, et al. Refractory primary central nervous system vasculitis of childhood: successful treatment with infliximab. J Rheumatol. 2012;39(11):2227–2229.
- Liu Y, Jesus AA, Marrero B, et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med. 2014;371:507–518.
- Navon Elkan P, Pierce SB, Segel R, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370(10):921–931.
- Cellucci T, Tyrrell PN, Sheikh S, et al. Childhood primary angiitis of the central nervous system: identifying disease trajectories and early risk factors for persistently higher disease activity. Arthritis Rheum. 2012;64(5):1665–1672
•The analysis of a pediatric cohort of PACNS suggests the existence of different clinical patterns. Patients with angiography-negative disease and seizures at presentation experience higher disease activity.
- Salvarani C, Hunder GG, Morris JM, et al. A-beta-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis. Neurology. 2013;81(18):1596–1603.